Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors

被引:2
作者
Bermejo, M
Sánchez-Palomino, S
Usán, L
Alcamí, J
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, AIDS Immunopathogenesis Unit, Madrid 28220, Spain
[2] Abbott Labs, Dept Med, Madrid, Spain
关键词
latency; reactivation; protease inhibitors; pharmacodynamics; viral escape HIV;
D O I
10.1002/jmv.20118
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Using a system that allows transfection of resting peripheral blood lymphocytes (PBLs) two questions were addressed: the kinetics of HIV replication from the state of proviral latency, and the impact of different parameters on the efficacy of protease inhibitors to control HIV replication. PBLs were transfected with an infectious full length HIV-DNA harboring a luciferase reporter gene and activated thereafter. Ritonavir was added at different times at doses ranging from to 0.06 to 1 muM. Viral expression was assessed by quantifying luciferase activity in cell extracts and levels of p24 HIV antigen in culture supernatants. After transfection and cell activation, intracellular expression of HIV proteins, as assessed by luciferase detection, occurred within 2 hr. HIV-gag p24 antigen was detected in culture supernatants between 6 and 8 hr post-activation. Ritonavir was effective in blocking viral replication when given within 4 hr following HIV reactivation, but a delay in ritonavir administration or breaches in ritonavir levels after 6 hr from transfection resulted in viral escape. HIV reactivation from proviral latency in PBLs is an extremely rapid process, faster than estimated from previous models. These data stress the need for maintaining effective antiretroviral concentrations to block completely viral replication. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:502 / 507
页数:6
相关论文
共 31 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   ABSOLUTE DEPENDENCE ON KAPPA-B RESPONSIVE ELEMENTS FOR INITIATION AND TAT-MEDIATED AMPLIFICATION OF HIV TRANSCRIPTION IN BLOOD CD4 T-LYMPHOCYTES [J].
ALCAMI, J ;
DELERA, TL ;
FOLGUEIRA, L ;
PEDRAZA, MA ;
JACQUE, JM ;
BACHELERIE, F ;
NORIEGA, AR ;
HAY, RT ;
HARRICH, D ;
GAYNOR, RB ;
VIRELIZIER, JL ;
ARENZANASEISDEDOS, F .
EMBO JOURNAL, 1995, 14 (07) :1552-1560
[3]  
ALCAMI J, 12 INT AIDS C DURB S
[4]   The challenge of viral reservoirs in HIV-1 infection [J].
Blankson, JN ;
Persaud, D ;
Siliciano, RF .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :557-593
[5]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[6]   A review of low-dose ritonavir in protease inhibitor combination therapy [J].
Cooper, CL ;
van Heeswijk, RPG ;
Gallicano, K ;
Cameron, DW .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (12) :1585-1592
[7]   Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy [J].
Descamps, D ;
Flandre, P ;
Calvez, V ;
Peytavin, G ;
Meiffredy, V ;
Collin, G ;
Delaugerre, C ;
Robert-Delmas, S ;
Bazin, B ;
Aboulker, JP ;
Pialoux, G ;
Raffi, F ;
Brun-Vézinet, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02) :205-211
[8]   Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration [J].
Detels, R ;
Muñoz, A ;
McFarlane, G ;
Kingsley, LA ;
Margolick, JB ;
Giorgi, J ;
Scharager, LD ;
Phair, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17) :1497-1503
[9]   Factors influencing the emergence of resistance to indinavir: Role of virologic, immunologic, and pharmacologic variables [J].
Drusano, GL ;
Bilello, JA ;
Stein, DS ;
Nessly, M ;
Meibohm, A ;
Emini, EA ;
Deutsch, P ;
Condra, J ;
Chodakewitz, J ;
Holder, DJ .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :360-367
[10]   Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].
Finzi, D ;
Blankson, J ;
Siliciano, JD ;
Margolick, JB ;
Chadwick, K ;
Pierson, T ;
Smith, K ;
Lisziewicz, J ;
Lori, F ;
Flexner, C ;
Quinn, TC ;
Chaisson, RE ;
Rosenberg, E ;
Walker, B ;
Gange, S ;
Gallant, J ;
Siliciano, RF .
NATURE MEDICINE, 1999, 5 (05) :512-517